Trials / Completed
CompletedNCT04254575
Understanding Daily Changes in BDD Risk Using Smartphones
Smartphone-based Digital Phenotyping to Detect High-risk Affect States in Body Dysmorphic Disorder (BDD)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 87 (actual)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Body dysmorphic disorder (BDD) is associated with high risk for suicide attempts (22-28%) and substance use disorders (49%), underscoring the importance of accurate, real-time risk detection in BDD. This study aims to use smartphone-based digital phenotyping to develop and validate unobtrusive, time-sensitive, and ecologically valid measures of key risk factors for suicide and substance misuse in BDD: negative affect states. As next steps, this research can be extended to detect risk transdiagnostically, with the goal of enabling just-in-time interventions to target suicide and substance misuse across psychiatric illnesses.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | None, observational study only (no interventions) | None, observational study only (no interventions) |
Timeline
- Start date
- 2020-07-15
- Primary completion
- 2023-04-28
- Completion
- 2023-04-28
- First posted
- 2020-02-05
- Last updated
- 2023-09-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04254575. Inclusion in this directory is not an endorsement.